Background:
Aquaporins facilitate passive, bidirectional water transport in all cells and tissues. In the brain and spinal cord, aquaporin-4 facilitates the exchange of water across the blood-spinal cord and blood-brain barriers, controlling cell volume, extracellular space volume and astrocyte migration. Recently, we have demonstrated that aquaporin-4 localisation is dynamically regulated at the subcellular level, affecting membrane water permeability. In animal models of ageing, stroke, traumatic injury and sleep disruption, all risk factors for neurodegeneration, both glymphatic function and aquaporin-4 perivascular localisation are reduced. Brain and spinal cord oedema are caused by the influx of water through aquaporin-4 following insults such as traumatic injury, stroke or cancer. We have demonstrated that reducing dynamic subcellular relocalisation of aquaporin-4 to the blood-spinal cord or blood-brain barriers reduces oedema and accelerates functional recovery in rodent injury models. Targeting dynamic aquaporin-4 subcellular relocalisation provides a novel approach to modulating aquaporin-4 function for clinical benefit.
Objective:
This PhD project aims to understand how aquaporin-4 localisation is regulated in health and disease using in vitro and/or in vivo methods. We will use a suite of cutting-edge biochemical and biophysical approaches to characterise this regulation.
The long-term impacts of this project will be the identification of a mechanistic framework to understand the fundamental physiological process of brain water homeostasis and the use of this knowledge to prevent brain swelling and neurodegeneration, contributing to an urgent and unmet clinical need for new effective medicines.
Key Papers:
Salman MM et al. Emerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis, Brain, 2022, 145, 64-75 (Featured on the front cover).
Salman MM, Kitchen P, Yool AJ and Bill RM: Recent breakthroughs and future directions in drugging aquaporins, Trends Pharmacol Sci, 2022, 43,30-42 (Featured on the front cover).
Kitchen P et al.: Targeting aquaporin-4 subcellular localization to treat central nervous system edema, Cell, 2020, 181, 784-799.